By G HossainPosted on July 27, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease. Argenx deepens immuno expertise with $2.2B Forte Biosciences buy Post navigation Amgen lays off around 40 employeesAstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
